The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Cancer treatment and survivorship statistics, 2014
Open accessAbstract
The number of cancer survivors continues to increase due to the aging and growth of the population and improvements in early detection and treatment. In order for the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborated to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results (SEER) program registries. In addition, current treatment patterns for the most common cancer types are described based on information in the National Cancer Data Base and the SEER and SEER‐Medicare linked databases; treatment‐related side effects are also briefly described. Nearly 14.5 million Americans with a history of cancer were alive on January 1, 2014; by January 1, 2024, that number will increase to nearly 19 million. The 3 most common prevalent cancers among males are prostate cancer (43%), colorectal cancer (9%), and melanoma (8%), and those among females are cancers of the breast (41%), uterine corpus (8%), and colon and rectum (8%). The age distribution of survivors varies substantially by cancer type. For example, the majority of prostate cancer survivors (62%) are aged 70 years or older, whereas less than one‐third (32%) of melanoma survivors are in this older age group. It is important for clinicians to understand the unique medical and psychosocial needs of cancer survivors and to proactively assess and manage these issues. There are a growing number of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. CA Cancer J Clin 2014;64:252–271. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Self-citationSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,403
Self-citationMutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407
Persistent postsurgical pain: risk factors and prevention
Kehlet, H., Jensen, T. S., & Woolf, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68700-x · Cited by 4,086
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209096 · Cited by 2,796
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Self-citationColorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Self-citationEffect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Childhood and adolescent cancer statistics, 2014
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21219 · Cited by 2,412
Self-citationIncidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
DiSipio, T., Rye, S., Newman, B., & Hayes, S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70076-7 · Cited by 1,885
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
Pellegriti, G., Frasca, F., Regalbuto, C., Squatrito, S., & Vigneri, R. (2013) · Journal of Cancer Epidemiology · doi:10.1155/2013/965212 · Cited by 1,288
Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
Hudson, M. M., Ness, K. K., Gurney, J. G., Mulrooney, D. A., Chemaitilly, W., Krull, K. R., Green, D. M., Armstrong, G. T., Nottage, K. A., Jones, K. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.6296 · Cited by 1,248
Edwards, B. K., Noone, A., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., Jemal, A., Cho, H., Anderson, R. N., Kohler, B. A., et al. (2014) · Cancer · doi:10.1002/cncr.28509 · Cited by 1,210
Self-citation20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Spier, C. M., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E., & Fisher, R. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390104 · Cited by 1,004
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
Resnick, M. J., Koyama, T., Fan, K.-H., Albertsen, P. C., Goodman, M., Hamilton, A. S., Hoffman, R. M., Potosky, A. L., Stanford, J. L., Stroup, A. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209978 · Cited by 979
Superficial Bladder Cancer: Progression and Recurrence
Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., Hawkins, I. R., & For National Bladder Cancer Collaborative Group A S002253471751695X-1bb6d6502e02ba4ea1210f9f5bd6022d George R. Prout The principal investigators and institutions that contributed to the study are, M. G. H. (1983) · Journal of Urology · doi:10.1016/s0022-5347(17)51695-x · Cited by 924
Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery
Gärtner, R., Jensen, M.-B., Nielsen, J., Ewertz, M., Kroman, N., & Kehlet, H. (2009) · JAMA · doi:10.1001/jama.2009.1568 · Cited by 908
Howard-Anderson, J., Ganz, P. A., Bower, J. E., & Stanton, A. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr541 · Cited by 830 · cited 1×
“In addition, treatment with chemotherapy can lead to impaired fertility and premature menopause, which increases the risk of osteoporosis.(34) Anthracyclines and HER2-targeted drugs can lead to cardiomyopathy and congestive heart failure.”
BackgroundMoorman, A. V., Harrison, C. J., Buck, G. A. N., Richards, S. M., Secker-Walker, L. M., Martineau, M., Vance, G. H., Cherry, A. M., Higgins, R. R., Fielding, A. K., et al. (2007) · Blood · doi:10.1182/blood-2006-10-051912 · Cited by 753
American Cancer Society lung cancer screening guidelines
Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., Etzioni, R., Flowers, C. R., Scott Gazelle, G., Kelsey, D. K., et al. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21172 · Cited by 723
Keating, N. L., O'Malley, A. J., Freedland, S. J., & Smith, M. R. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp404 · Cited by 622
The 2010 NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer
Mohler, J. L. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0010 · Cited by 614
Boissel, N., Auclerc, M.-F., Lhéritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.-M., Gabert, J., Fegueux, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.053 · Cited by 608
Meadows, A. T., Friedman, D. L., Neglia, J. P., Mertens, A. C., Donaldson, S. S., Stovall, M., Hammond, S., Yasui, Y., & Inskip, P. D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1920 · Cited by 524
Jagsi, R., Jiang, J., Momoh, A. O., Alderman, A., Giordano, S. H., Buchholz, T. A., Kronowitz, S. J., & Smith, B. D. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.2284 · Cited by 442
Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
Pui, C.-H., Behm, F. G., Raimondi, S. C., Dodge, R. K., George, S. L., Rivera, G. K., Mirro, J., Kalwinsky, D. K., Dahl, G. V., Murphy, S. B., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210302 · Cited by 441
Efstathiou, J. A., Spiegel, D. Y., Shipley, W. U., Heney, N. M., Kaufman, D. S., Niemierko, A., Coen, J. J., Skowronski, R. Y., Paly, J. J., McGovern, F. J., et al. (2012) · European Urology · doi:10.1016/j.eururo.2011.11.010 · Cited by 435
Nguyen, P. L., Je, Y., Schutz, F. A. B., Hoffman, K. E., Hu, J. C., Parekh, A., Beckman, J. A., & Choueiri, T. K. (2011) · JAMA · doi:10.1001/jama.2011.1745 · Cited by 432
Outcomes of Localized Prostate Cancer Following Conservative Management
Lu-Yao, G. L. (2009) · JAMA · doi:10.1001/jama.2009.1348 · Cited by 430
Prognostic Parameters in Superficial Bladder Cancer: An Analysis of 315 Cases
Lutzeyer, W., Rübben, H., & Dahm, H. (1982) · Journal of Urology · doi:10.1016/s0022-5347(17)53725-8 · Cited by 426
Weight Lifting for Women at Risk for Breast Cancer–Related Lymphedema: A Randomized Trial
Schmitz, K. H., Ahmed, R. L., Troxel, A. B., Cheville, A., Lewis-Grant, L., Smith, R., Bryan, C. J., Williams-Smith, C. T., & Chittams, J. (2010) · JAMA · doi:10.1001/jama.2010.1837 · Cited by 410
Weaver, K. E., Forsythe, L. P., Reeve, B. B., Alfano, C. M., Rodriguez, J. L., Sabatino, S. A., Hawkins, N. A., & Rowland, J. H. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0740 · Cited by 398
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
Pui, C.-H., & Howard, S. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70070-6 · Cited by 393
Lawenda, B. D., Mondry, T. E., & Johnstone, P. A. S. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20001 · Cited by 377
Bilimoria, K. Y., Bentrem, D. J., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7018 · Cited by 373
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
Saylor, P. J., & Smith, M. R. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.01.047 · Cited by 349
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
Alibhai, S. M. H., Duong-Hua, M., Sutradhar, R., Fleshner, N. E., Warde, P., Cheung, A. M., & Paszat, L. F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0923 · Cited by 334
McGuire, K. P., Santillan, A. A., Kaur, P., Meade, T., Parbhoo, J., Mathias, M., Shamehdi, C., Davis, M., Ramos, D., & Cox, C. E. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0635-x · Cited by 326
Young Adult Oncology: The Patients and Their Survival Challenges
Bleyer, A. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.4.242 · Cited by 324
Quality of life among long-term (⩾5 years) colorectal cancer survivors – Systematic review
Jansen, L., Koch, L., Brenner, H., & Arndt, V. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.010 · Cited by 322
Multiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship
Mariotto, A. B., Rowland, J. H., Ries, L. A. G., Scoppa, S., & Feuer, E. J. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0782 · Cited by 283
Self-citationLerro, C. C., Robbins, A. S., Phillips, J. L., & Stewart, A. K. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2901-1 · Cited by 280
Self-citationA systematic review of the impact of stigma and nihilism on lung cancer outcomes
Chambers, S. K., Dunn, J., Occhipinti, S., Hughes, S., Baade, P., Sinclair, S., Aitken, J., Youl, P., & O’Connell, D. L. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-184 · Cited by 258
The Influence of Socioeconomic Disparities on Breast Cancer Tumor Biology and Prognosis: A Review
Vona-Davis, L. C., & Rose, D. P. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.1127 · Cited by 247
Nam, R. K., Cheung, P., Herschorn, S., Saskin, R., Su, J., Klotz, L. H., Chang, M., Kulkarni, G. S., Lee, Y., Kodama, R. T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70606-5 · Cited by 235
Ten‐year outcomes of high‐dose, intensity‐modulated radiotherapy for localized prostate cancer
Alıcıkuş, Z. A., Yamada, Y. J., Zhang, Z., Pei, X., Hunt, M. A., Kollmeier, M. A., Cox, B. W., & Zeléfsky, M. J. (2010) · Cancer · doi:10.1002/cncr.25467 · Cited by 227
Jatoi, I., & Proschan, M. A. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000156922.58631.d7 · Cited by 227
Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Thorstenson, Y., Oefner, P. J., Brown, P. O., Botstein, D., & Levy, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132253599 · Cited by 226
Vilholm, O. J., Cold, S., Rasmussen, L., & Sindrup, S. H. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604534 · Cited by 225
Disparities in cancer outcomes: Lessons learned from children with cancer
Bhatia, S. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23078 · Cited by 203
The biology and therapy of adult acute lymphoblastic leukemia
Faderl, S. H., Jeha, S., & Kantarjian, H. M. (2003) · Cancer · doi:10.1002/cncr.11664 · Cited by 195
Hallböök, H., Gustafsson, G., Smedmyr, B., Söderhäll, S., Heyman, M. M., & for the Swedish Adult Acute Lymphocytic Leukemia Group and the Swedish Childhood Leukemia Group (2006) · Cancer · doi:10.1002/cncr.22189 · Cited by 194
Recent advances in the diagnosis and treatment of bladder cancer
Cheung, G., Sahai, A., Billia, M., Prokar Dasgupta, A., & Khan, M. S. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-13 · Cited by 190
Use of Radioactive Iodine for Thyroid Cancer
Haymart, M. R., Banerjee, M., Stewart, A. K., Koenig, R. J., Birkmeyer, J. D., & Griggs, J. J. (2011) · JAMA · doi:10.1001/jama.2011.1139 · Cited by 189
Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., Milani, R. V., Sagalowsky, A. I., Smith, M. R., Zakai, N., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20061 · Cited by 188
Which drug, and when, for patients with BRAF-mutant melanoma?
Jang, S., & Atkins, M. B. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70539-9 · Cited by 182
Parsons, H. M., Harlan, L. C., Seibel, N. L., Stevens, J. L., & Keegan, T. H. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2954 · Cited by 180
Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary
Kluetz, P. G., Pierce, W. F., Maher, V. E., Zhang, H., Tang, S. W., Song, P., Liu, Q., Haber, M. T., Leutzinger, E. E., Al-Hakim, A. H., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2665 · Cited by 179
State-of-the-Art Therapeutics: Diffuse Large B-Cell Lymphoma
Coiffier, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.015 · Cited by 178
Polednak, A. P. (2008) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2008.08.004 · Cited by 164
Fedewa, S. A., Ward, E. M., Stewart, A. K., & Edge, S. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2427 · Cited by 164
Митин, Т., Hunt, D. L., Shipley, W. U., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70255-9 · Cited by 163
Racial and ethnic differences in breast cancer survival
Curtis, E., Quale, C., Haggstrom, D., & Smith-Bindman, R. (2008) · Cancer · doi:10.1002/cncr.23131 · Cited by 157
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
Saylor, P. J., & Smith, M. R. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.11.017 · Cited by 141
Danforth, D. N. (2013) · Breast Cancer Research · doi:10.1186/bcr3429 · Cited by 137
Improving quality of life after breast cancer: Dealing with symptoms
Pinto, A. C., & de Azambuja, E. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.09.008 · Cited by 135
Tada, H., Teramukai, S., Fukushima, M., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-47 · Cited by 131
Steegers, M. A. H., Wolters, B., Evers, A. W. M., Strobbe, L. J. A., & Wilder‐Smith, O. H. G. (2008) · Journal of Pain · doi:10.1016/j.jpain.2008.04.001 · Cited by 129
Central Role of RET in Thyroid CancerPreprint
Santoro, M. M., & Carlomagno, F. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009233 · Cited by 120
Estimation and projections of cancer prevalence from cancer registry data
Verdecchia, A., Angelis, G. D., & Capocaccia, R. (2002) · Statistics in Medicine · doi:10.1002/sim.1304 · Cited by 119
Wadhwa, V. K., Weston, R., Mistry, R., & Parr, N. J. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08483.x · Cited by 117
Prediagnosis Body Mass Index, Physical Activity, and Mortality in Endometrial Cancer Patients
Arem, H. E., Park, Y., Pelser, C. B., Ballard-Barbash, R. R., Irwin, M. L., Hollenbeck, A. R., Gierach, G. L., Brinton, L. A., Pfeiffer, R. M., & Matthews, C. E. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs530 · Cited by 117
Brennan, M. E., & Spillane, A. J. (2013) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2013.02.021 · Cited by 109 · cited 2×
“Studies suggest that reconstruction is offered to only a fraction of eligible women.(22) Among women diagnosed with early-stage (stage I or II)”
BackgroundShappley, W. V., Kenfield, S. A., Kasperzyk, J. L., Qiu, W., Stampfer, M. J., Sanda, M. G., & Chan, J. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2613 · Cited by 100
Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases
Costa, L. J., Xavier, A. C., Wahlquist, A. E., & Hill, E. G. (2013) · Blood · doi:10.1182/blood-2012-12-475558 · Cited by 95
Willemse, P.-P. M., Burggraaf, J., Hamdy, N. A. T., Weijl, N. I., VOSSEN, C. Y., van Wulften, L., Tol, A. Q. M. J. V. S.-V., Rosendaal, F. R., & Osanto, S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.226 · Cited by 93
Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer
Hoffman-Censits, J. H., & Kelly, W. K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2910 · Cited by 92
Bhargava, A., & Du, X. L. (2009) · Cancer · doi:10.1002/cncr.24363 · Cited by 68
The Sexual Health of Women After Gynecologic Malignancy
Audette, C., & Waterman, J. (2010) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2009.10.016 · Cited by 67
Lee, C. N., Belkora, J. K., Chang, Y., Moy, B., Partridge, A. H., & Sepucha, K. (2011) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181f958de · Cited by 64
Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer
Aghili, M., Izadi, S., MADANI, H., & MORTAZAVI, H. (2010) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2010.01275.x · Cited by 64
Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin
Balamurugan, A., Rees, J. R., Kosary, C. L., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.033 · Cited by 63
Hematological changes during androgen deprivation therapy
Grossmann, M., & Zajac, J. D. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.102 · Cited by 62
Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000–2020
Mariotto, A. B., Yabroff, K. R., Feuer, E. J., Angelis, R. D., & Brown, M. L. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0072-0 · Cited by 59
Self-citationConte, P., & Frassoldati, A. (2007) · The Breast Journal · doi:10.1111/j.1524-4741.2006.00359.x · Cited by 54
Roghmann, F., Becker, A., Trinh, Q., et al. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.221 · Cited by 44
Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy
Leung, E., Warde, P. R., Jewett, M. A. S., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12330 · Cited by 42
Richter's Transformation of Chronic Lymphocytic Leukemia
Giardino, A. A., O'Regan, K. N., Jagannathan, J. P., Elco, C., Ramaiya, N. H., & LaCasce, A. S. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.6579 · Cited by 41
Richter's transformation in chronic lymphocytic leukemia.
Jain, P., & O'Brien, S. (2012) · PubMed · Cited by 40
The Adolescence of Young Adult Oncology
Albritton, K. H., Barr, R. D., & Bleyer, A. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.07.007 · Cited by 39
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Tsai, H. K., & Mauch, P. (2007) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2007.02.004 · Cited by 37
Well‐differentiated thyroid carcinoma: The role of post‐operative radioactive iodine administration
Patel, S. S., & Goldfarb, M. R. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23295 · Cited by 32
Birkhahn, M., Penson, D. F., Cai, J., Groshen, S. G., Stein, J. P., Lieskovsky, G., Skinner, D. G., & Côté, R. J. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09978.x · Cited by 24
O’Malley, C. D., Danese, M. D., Lindquist, K. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.11050 · Cited by 4
Cited by
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Self-citationTumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Riquelme, E., Zhang, Y., Zhang, L., Montiel, M., Zoltan, M., Dong, W., Quesada, P., Sahin, I., Chandra, V., San Lucas, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.008 · Cited by 1,577
“Despite this, a minor subset of patients survive more than 5-years post-surgery (Dal Molin et al., 2015; DeSantis et al., 2014).”
BackgroundRunowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan
Longo, V. D., & Panda, S. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.001 · Cited by 1,013
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
Metadata
- Authors
- DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., Alteri, R., Robbins, A. S., & Jemal, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2014-06
- Volume
- 64
- Issue
- 4
- Pages
- 252-271
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2327362588
- Cited by
- 2,779
- References
- 100
- FWCI
- 196.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.